Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Proteomic analysis of neutrophils in ANCA-associated vasculitis reveals a dysregulation in proteinase 3-associated proteins such as annexin-A1 involved in apoptotic cell clearance.

Everts-Graber J, Martin KR, Thieblemont N, Mocek J, Roccabianca A, Chafey P, Le Gall M, Tacnet-Delorme P, Reutelingsperger CP, Naccache JM, Bonnotte B, Karras A, Puéchal X, Guillevin L, Terrier B, Frachet P, Perretti M, Mouthon L, Witko-Sarsat V.

Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30269-8. doi: 10.1016/j.kint.2019.02.017. [Epub ahead of print]

PMID:
31142442
2.

Expanding Neutrophil Horizons: New Concepts in Inflammation.

Chatfield SM, Thieblemont N, Witko-Sarsat V.

J Innate Immun. 2018;10(5-6):422-431. doi: 10.1159/000493101. Epub 2018 Sep 26. Review.

3.

Regulation of macrophage activation by proteins expressed on apoptotic neutrophils: Subversion towards autoimmunity by proteinase 3.

Thieblemont N, Witko-Sarsat V, Ariel A.

Eur J Clin Invest. 2018 Nov;48 Suppl 2:e12990. doi: 10.1111/eci.12990. Review.

PMID:
30039869
4.

Proteinase 3 Interferes With C1q-Mediated Clearance of Apoptotic Cells.

Tacnet-Delorme P, Gabillet J, Chatfield S, Thieblemont N, Frachet P, Witko-Sarsat V.

Front Immunol. 2018 Apr 25;9:818. doi: 10.3389/fimmu.2018.00818. eCollection 2018.

5.

[Communication at the heart of effective group work].

Bodart G, Hamann É, Thieblemont N.

Rev Infirm. 2018 Mar;67(239):44-45. doi: 10.1016/j.revinf.2018.01.012. Review. French.

PMID:
29525016
6.

Transgenic Mice Expressing Human Proteinase 3 Exhibit Sustained Neutrophil-Associated Peritonitis.

Martin KR, Pederzoli-Ribeil M, Pacreau E, Burgener SS, Dahdah A, Candalh C, Lauret E, Foretz M, Mouthon L, Lucas B, Thieblemont N, Benarafa C, Launay P, Witko-Sarsat V.

J Immunol. 2017 Dec 1;199(11):3914-3924. doi: 10.4049/jimmunol.1601522. Epub 2017 Oct 27.

7.

Granulomatosis with polyangiitis (Wegener granulomatosis): A proteinase-3 driven disease?

Witko-Sarsat V, Thieblemont N.

Joint Bone Spine. 2018 Mar;85(2):185-189. doi: 10.1016/j.jbspin.2017.05.004. Epub 2017 May 8.

PMID:
28495524
8.

MyD88 modulates eosinophil and neutrophil recruitment as well as IL-17A production during allergic inflammation.

Pham Van L, Germaud N, Ramadan A, Thieblemont N.

Cell Immunol. 2016 Dec;310:116-122. doi: 10.1016/j.cellimm.2016.08.014. Epub 2016 Aug 26.

PMID:
27614844
9.

Human neutrophils in auto-immunity.

Thieblemont N, Wright HL, Edwards SW, Witko-Sarsat V.

Semin Immunol. 2016 Apr;28(2):159-73. doi: 10.1016/j.smim.2016.03.004. Epub 2016 Mar 29. Review.

PMID:
27036091
10.

Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.

Martin C, Ohayon D, Alkan M, Mocek J, Pederzoli-Ribeil M, Candalh C, Thevenot G, Millet A, Tamassia N, Cassatella MA, Thieblemont N, Burgel PR, Witko-Sarsat V.

Am J Respir Cell Mol Biol. 2016 May;54(5):740-50. doi: 10.1165/rcmb.2015-0047OC.

PMID:
26517580
11.

Dividing the Janus vasculitis? Pathophysiology of eosinophilic granulomatosis with polyangitis.

Chaigne B, Terrier B, Thieblemont N, Witko-Sarsat V, Mouthon L.

Autoimmun Rev. 2016 Feb;15(2):139-45. doi: 10.1016/j.autrev.2015.10.006. Epub 2015 Oct 23. Review.

PMID:
26506114
12.

Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.

Millet A, Martin KR, Bonnefoy F, Saas P, Mocek J, Alkan M, Terrier B, Kerstein A, Tamassia N, Satyanarayanan SK, Ariel A, Ribeil JA, Guillevin L, Cassatella MA, Mueller A, Thieblemont N, Lamprecht P, Mouthon L, Perruche S, Witko-Sarsat V.

J Clin Invest. 2015 Nov 2;125(11):4107-21. doi: 10.1172/JCI78182. Epub 2015 Oct 5.

13.

Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice.

Alkan M, Machavoine F, Rignault R, Dam J, Dy M, Thieblemont N.

J Diabetes Res. 2015;2015:965056. doi: 10.1155/2015/965056. Epub 2015 May 18.

14.

Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12.

Melero I, Quetglas JI, Reboredo M, Dubrot J, Rodriguez-Madoz JR, Mancheño U, Casales E, Riezu-Boj JI, Ruiz-Guillen M, Ochoa MC, Sanmamed MF, Thieblemont N, Smerdou C, Hervas-Stubbs S.

Cancer Res. 2015 Feb 1;75(3):497-507. doi: 10.1158/0008-5472.CAN-13-3356. Epub 2014 Dec 19.

15.

Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming.

Hervas-Stubbs S, Riezu-Boj JI, Mancheño U, Rueda P, Lopez L, Alignani D, Rodríguez-García E, Thieblemont N, Leclerc C.

J Immunol. 2014 Aug 1;193(3):1151-61. doi: 10.4049/jimmunol.1301440. Epub 2014 Jun 27.

16.

HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10.

Ben Haij N, Leghmari K, Planès R, Thieblemont N, Bahraoui E.

Retrovirology. 2013 Oct 28;10:123. doi: 10.1186/1742-4690-10-123.

17.

Activation of basophils by the double-stranded RNA poly(A:U) exacerbates allergic inflammation.

Ramadan A, Pham Van L, Machavoine F, Dietrich C, Alkan M, Karasuyama H, Schneider E, Dy M, Thieblemont N.

Allergy. 2013 Jun;68(6):732-8. doi: 10.1111/all.12151. Epub 2013 Apr 27.

PMID:
23621380
18.

Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms.

Van LP, Bardel E, Gregoire S, Vanoirbeek J, Schneider E, Dy M, Thieblemont N.

Eur J Immunol. 2011 Jul;41(7):1992-9. doi: 10.1002/eji.201040914. Epub 2011 Jun 6.

19.

The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.

Grela F, Aumeunier A, Bardel E, Van LP, Bourgeois E, Vanoirbeek J, Leite-de-Moraes M, Schneider E, Dy M, Herbelin A, Thieblemont N.

J Immunol. 2011 Jan 1;186(1):284-90. doi: 10.4049/jimmunol.1001348. Epub 2010 Dec 3.

20.

Basophils: new players in the cytokine network.

Schneider E, Thieblemont N, De Moraes ML, Dy M.

Eur Cytokine Netw. 2010 Sep;21(3):142-53. doi: 10.1684/ecn.2010.0197. Review.

21.

Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice.

Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, Gomez Alcala A, Jeannin P, Akira S, Bach JF, Thieblemont N.

PLoS One. 2010 Jul 7;5(7):e11484. doi: 10.1371/journal.pone.0011484.

22.

WITHDRAWN: Immunoregulatory responses induced through TLRs and potential therapeutic implications for autoimmune diseases.

Aumeunier A, Grela F, Bardel E, Damotte D, Akira S, Dy M, Thieblemont N, Bach JF.

J Autoimmun. 2008 Nov 21. [Epub ahead of print]

PMID:
19028078
23.

Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation.

Ahui ML, Champy P, Ramadan A, Pham Van L, Araujo L, Brou André K, Diem S, Damotte D, Kati-Coulibaly S, Offoumou MA, Dy M, Thieblemont N, Herbelin A.

Int Immunopharmacol. 2008 Dec 10;8(12):1626-32. doi: 10.1016/j.intimp.2008.07.009. Epub 2008 Aug 8.

PMID:
18692598
24.

TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help.

Hervas-Stubbs S, Olivier A, Boisgerault F, Thieblemont N, Leclerc C.

Blood. 2007 Jun 15;109(12):5318-26. Epub 2007 Mar 5.

25.

Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.

You S, Thieblemont N, Alyanakian MA, Bach JF, Chatenoud L.

Immunol Rev. 2006 Aug;212:185-202. Review.

PMID:
16903915
26.

Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes.

Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, Bardel E, Normier G, Chatenoud L, Thieblemont N, Bach JF.

Diabetes. 2006 Jan;55(1):179-85.

27.

Atheroprotective effect of adjuvants in apolipoprotein E knockout mice.

Khallou-Laschet J, Tupin E, Caligiuri G, Poirier B, Thieblemont N, Gaston AT, Vandaele M, Bleton J, Tchapla A, Kaveri SV, Rudling M, Nicoletti A.

Atherosclerosis. 2006 Feb;184(2):330-41. Epub 2005 Jul 26.

PMID:
16051252
28.

Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors.

Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M, Maina V, Magistrelli G, Haeuw JF, Hoeffel G, Thieblemont N, Corvaia N, Garlanda C, Delneste Y, Mantovani A.

Immunity. 2005 May;22(5):551-60.

29.

Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells.

Aksoy E, Zouain CS, Vanhoutte F, Fontaine J, Pavelka N, Thieblemont N, Willems F, Ricciardi-Castagnoli P, Goldman M, Capron M, Ryffel B, Trottein F.

J Biol Chem. 2005 Jan 7;280(1):277-83. Epub 2004 Nov 1.

30.

Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.

Chalifour A, Jeannin P, Gauchat JF, Blaecke A, Malissard M, N'Guyen T, Thieblemont N, Delneste Y.

Blood. 2004 Sep 15;104(6):1778-83. Epub 2004 May 27.

31.

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Varadaradjalou S, Féger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock M.

Eur J Immunol. 2003 Apr;33(4):899-906.

32.

Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies.

Jeannin P, Magistrelli G, Goetsch L, Haeuw JF, Thieblemont N, Bonnefoy JY, Delneste Y.

Vaccine. 2002 Dec 19;20 Suppl 4:A23-7. Review.

PMID:
12477424
33.

Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.

Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K, Bihl F, Ryffel B.

J Immunol. 2002 Sep 15;169(6):3155-62.

34.

The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.

Ouaissi A, Guilvard E, Delneste Y, Caron G, Magistrelli G, Herbault N, Thieblemont N, Jeannin P.

J Immunol. 2002 Jun 15;168(12):6366-74.

35.
36.

Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages.

Ding A, Thieblemont N, Zhu J, Jin F, Zhang J, Wright S.

Infect Immun. 1999 Sep;67(9):4485-9.

37.

Transport of bacterial lipopolysaccharide to the golgi apparatus.

Thieblemont N, Wright SD.

J Exp Med. 1999 Aug 16;190(4):523-34.

38.

Enhancement of leukocyte response to lipopolysaccharide by secretory group IIA phospholipase A2.

Cai TQ, Thieblemont N, Wong B, Thieringer R, Kennedy BP, Wright SD.

J Leukoc Biol. 1999 Jun;65(6):750-6.

PMID:
10380895
39.
40.
41.

Flow-cytometric assessment of in vivo cytokine-producing monocytes in HIV-infected patients.

Estcourt C, Rousseau Y, Sadeghi HM, Thiéblemont N, Carreno MP, Weiss L, Haeffner-Cavaillon N.

Clin Immunol Immunopathol. 1997 Apr;83(1):60-7.

PMID:
9073537
42.

Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes.

Haeffner A, Thieblemont N, Déas O, Marelli O, Charpentier B, Senik A, Wright SD, Haeffner-Cavaillon N, Hirsch F.

J Immunol. 1997 Feb 1;158(3):1310-4.

PMID:
9013974
43.

Potential role of membrane internalization and vesicle fusion in adhesion of neutrophils in response to lipopolysaccharide and TNF.

Detmers PA, Thieblemont N, Vasselon T, Pironkova R, Miller DS, Wright SD.

J Immunol. 1996 Dec 15;157(12):5589-96.

PMID:
8955211
44.

CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection.

Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N.

Eur J Immunol. 1995 Dec;25(12):3418-24.

PMID:
8566032
45.
46.

Enhancing role of complement in HIV infection.

Mouhoub A, Thieblemont N, Delibrias C, Fischer E, Kazatchkine MD.

Clin Exp Immunol. 1994 Aug;97 Suppl 2:9-11. Review. No abstract available.

47.

CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

Thieblemont N, Haeffner-Cavaillon N, Ledur A, L'Age-Stehr J, Ziegler-Heitbrock HW, Kazatchkine MD.

Clin Exp Immunol. 1993 Apr;92(1):106-13.

48.

Complement enhancement of HIV infection is mediated by complement receptors.

Thieblemont N, Delibrias C, Fischer E, Weiss L, Kazatchkine MD, Haeffner-Cavaillon N.

Immunopharmacology. 1993 Mar-Apr;25(2):87-93. Review. No abstract available.

PMID:
8500986
49.

Complement activation by gp160 glycoprotein of HIV-1.

Thieblemont N, Haeffner-Cavaillon N, Weiss L, Maillet F, Kazatchkine MD.

AIDS Res Hum Retroviruses. 1993 Mar;9(3):229-33.

PMID:
8471312

Supplemental Content

Loading ...
Support Center